Agios Pharma (AGIO) Reports Q4 Loss of $1.08/Share

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.08), versus ($0.76) reported last year. Revenue for the quarter came in at $6.22 million, versus $14.64 million reported last year.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform